Health and AI Claims in Your Marketing Need Proof: What Recent FTC and NAD Activity Means for Practices
By Quantum Clinical Advisors

Illustrative photography; not the organization or people discussed.
If your website says your treatment is "proven," your practice is "the leader," or your new tool is "AI-powered," someone may ask you to back that up. Recent activity from the FTC and the advertising industry's self-regulator shows that health and AI claims are getting close attention right now.
What's happening
The National Advertising Division (NAD) is the ad industry's self-regulatory body, run by BBB National Programs. In September 2026 it reviewed advertising for an AI-enabled hearing aid and told the company to change or drop several claims, including "better hearing all around" and "the leader in hearing healthcare." The company agreed.
The reasons are useful for any healthcare marketer:
- A study has to match the claim. The company's consumer study showed a large share of people with no preference between products. NAD's long-standing rule of thumb is that when 20 percent or more of respondents have no preference, you should not make an unqualified "preferred" claim.
- "The leader" is different from "a leader." Leadership claims should be tied to clear metrics.
- AI-generated testing needs validation. NAD called AI testing an emerging area with real potential, but said it must be validated for the specific claim being made.
- "Proven" sets a high bar. For health and safety claims, the evidence generally needs to be well-controlled studies of the product itself.
The FTC has brought its own "AI-washing" cases, including cases about accuracy claims that were only supported in narrow conditions. In its October 2026 roundup, one law firm also noted that NAD plans to refer an AI company to the FTC after the company failed to respond to or substantiate its advertising claims.
Class actions are following. A recent suit against a wellness-shot maker alleges that its "immunity boost" claims are unsupported. These are allegations, not findings, but they show the kind of wording plaintiffs' lawyers are watching.
Reviews and testimonials count too
NAD also handled a case where a company was running an incentivized review program. The company agreed to change its practices to follow the FTC's Endorsement Guides, which call for clear disclosure when a reviewer was paid or reimbursed. If your practice offers a gift card, discount, or any perk for a review, that needs to be disclosed.
A quick self-check for your website
- Highlight every claim about outcomes, results, "best," "#1," "proven," or "clinically tested."
- Ask what supports each one. Do you have studies, data, or documentation that matches the exact wording?
- Narrow the wording if the proof is thinner than the claim. "Many of our patients report..." is easier to support than "guaranteed results."
- Check any AI language. If you mention AI, say what it actually does, and do not imply it replaces a clinician.
- Review testimonials and incentives for proper disclosure.
The takeaway
Strong marketing and careful marketing are not opposites. Claims that you can support build trust with patients and keep you out of trouble.
Quantum Clinical Advisors helps Hawaii practices review their websites and marketing for claims that need tightening. This post is general information, not legal advice. For specific questions, talk with a qualified attorney.
Sources
- DLA Piper, NAD's AI-washing cases remind advertisers to qualify performance claims and support comparative claims (opens in a new tab) (October 12, 2026).
- Simpson Thacher via Mondaq, The Ad Standard: Monthly Update – October 2026 (opens in a new tab) (October 15, 2026).
Want to discuss your practice’s website and marketing?
Book a free 15-minute call (opens in a new tab)